| Shares traded a day, averaged over the last 30 days. | Average return a year over the last three years. | The largest fall from a peak to the low that followed, over up to five years. | |||||||
|---|---|---|---|---|---|---|---|---|---|
| PPHVanEck Pharmaceutical ETF· VanEck | A | 73 | High | 0.36% | $1.0B | 251.1K | +29.1% | +13.8% | −20.3% |
| IHEiShares U.S. Pharmaceuticals ETF· IShares | B | 67 | Medium | 0.37% | $1.7B | 211.6K | +48.8% | +21.6% | −16.0% |
| XPHState Street SPDR S&P Pharmaceuticals ETF· SPDR | B | 66 | Medium | 0.35% | $558M | 116.2K | +48.0% | +20.6% | −30.9% |
| PBPHPortfolio Building Block World Pharma and Biotech Index ETF· Portfolio Building Block ETFs | B | 64 | Medium | 0.13% | $1.0B | 122.6K | — | — | — |
| PJPInvesco Pharmaceuticals ETF· Invesco | B | 62 | Medium | 0.58% | $554M | 30.8K | +39.1% | +21.5% | −17.5% |
| FTXHFirst Trust Nasdaq Pharmaceuticals ETF· First Trust | B | 56 | Medium | 0.60% | $1.1B | 561.7K | +50.8% | +19.1% | −19.5% |
| OZEMRoundhill Investments - GLP-1 & Weight Loss ETF· Roundhill Investments | C | 44 | Medium | 0.59% | $60M | 21.6K | +17.9% | — | −28.6% |
| THNRAmplify Weight Loss Drug & Treatment ETF· Amplify | C | 43 | High | 0.59% | $6M | 1.9K | +12.4% | — | −32.5% |
| PSILAdvisorShares Psychedelics ETF· AdvisorShares | F | 18 | Medium | 1.84% | $57M | 39.9K | +56.2% | +19.6% | −92.9% |